Preemptive Mpox Vaccine Deployment: Aligning Strategy With Reality
We appreciate Tsagkaris and colleagues' commentary on our study [1], which draws attention to key aspects of mpox vaccine deployment in Greece
Authors
- Jacco Wallinga (ORCID: https://orcid.org/0000-0003-1725-5627)
- Sung-mok Jung (ORCID: https://orcid.org/0000-0002-0787-4515)
- Hiroaki Murayama (ORCID: https://orcid.org/0000-0002-7219-5981)
- Fuminari Miura (ORCID: https://orcid.org/0000-0001-8235-757X)
- Justin Lessler (ORCID: https://orcid.org/0000-0002-9741-8109)
- Sebastian Funk (ORCID: https://orcid.org/0000-0002-2842-3406)
- Akira Endo (ORCID: https://orcid.org/0000-0001-6377-7296)
Institutions
- University of North Carolina at Chapel Hill (US)
- Johns Hopkins University (US)
- National University of Singapore (SG)
- Leiden University Medical Center (NL)
- London School of Hygiene & Tropical Medicine (GB)
- National Institute for Public Health and the Environment (NL)
- National University Health System (SG)
- Ehime University (JP)
- Nagasaki University (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1093/infdis/jiaf365
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Wellcome Trust
- European Commission
- Ministry of Education, Culture, Sports, Science and Technology
- Centers for Disease Control and Prevention
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Precursory Research for Embryonic Science and Technology